综述文章

蛋白酪氨酸磷酸酶-1B抑制剂研究进展

  • 刘霞;冯长根
展开
  • 1. 中国农业大学理学院,北京 100193;2. 北京理工大学机电学院,北京 100081

收稿日期: 2012-02-23

  修回日期: 2012-03-12

  网络出版日期: 2012-04-08

Research Progress on Inhibitors of Protein Tyrosine Phosphatase-1B

  • LIU Xia;FENG Changgen
Expand
  • 1. College of Science, China Agricultural University, Beijing 100193, China;2. School of Mechatronical Engineering, Beijing Institute of Technology, Beijing 100081, China

Received date: 2012-02-23

  Revised date: 2012-03-12

  Online published: 2012-04-08

摘要

蛋白酪氨酸磷酸酶-1B(PTP-1B)在胰岛素信号转导中起负调节作用,是治疗2型糖尿病和肥胖症的一个新靶点。PTP-1B抑制剂可有效治疗2型糖尿病和肥胖症。本文综述了近年来PTP-1B抑制剂的研究进展,重点归纳了通过化学合成方法得到了多种PTP-1B抑制剂,如钒酸盐类化合物、磷酸酯类化合物、肽类化合物等。

本文引用格式

刘霞;冯长根 . 蛋白酪氨酸磷酸酶-1B抑制剂研究进展[J]. 科技导报, 2012 , 30(10) : 72 -79 . DOI: 10.3981/j.issn.1000-7857.2012.10.011

Abstract

Protein-tyrosine phosphatase-1B acts as a negative regulator of the insulin signal transduction, serving as a new therapeutic target in type 2 diabetes and obesity. Inhibitors of PTP-1B may be beneficial in the treatment of type 2 diabetes and obesity. This paper reviews recent progresses of researches on inhibitors of PTP-1B, with PTP-1B inhibitors obtained by chemical synthesis being summarized, including vanadate compounds, phosphate compounds, peptide compounds and others.
文章导航

/